Methotrexate maintenance following Ingram therapy in 'difficult' psoriasis

Area of Science:

• Dermatology
• Clinical Medicine
• Pharmacology

Background:

• Psoriasis is a chronic inflammatory skin condition.
• Managing difficult psoriasis cases poses significant clinical challenges.
• Existing treatments may have limited long-term efficacy for severe psoriasis.

Purpose of the Study:

• To evaluate the long-term effectiveness of a combined Ingram therapy and methotrexate maintenance regimen.
• To assess the impact of this combined therapy on remission duration and re-admission rates in severe psoriasis patients.
• To analyze 9 years of clinical experience with this treatment protocol.

Main Methods:

• Retrospective analysis of 9 years of patient data.
• Involved a combined therapeutic approach: Ingram therapy followed by methotrexate maintenance.
• Focused on patients with particularly difficult-to-manage psoriasis.

Main Results:

• The combined therapy significantly extended the lesion-free period from approximately 1 month to 1 year.
• The time before re-admission was extended from about 5 months to over 3 years.
• Demonstrated sustained efficacy in maintaining remission for severe psoriasis.

Conclusions:

• A combined Ingram therapy and methotrexate maintenance regimen is highly effective for long-term management of difficult psoriasis.
• This approach offers a substantial improvement in disease control and quality of life for affected patients.
• Supports the use of this sequential therapy in clinical practice for recalcitrant psoriasis cases.